Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Newly Diagnosed
100%
Prognostic Value
100%
Metastatic Breast Cancer
100%
Overall Survival
100%
Hazard Ratio
100%
Fluorodeoxyglucose
100%
Total Lesion Glycolysis
83%
SUVmax
83%
Lung
66%
Lymph Node
66%
Liver
66%
Metabolic Tumor Volume
50%
Metastasis
33%
Bone Metastasis
33%
Breast Cancer Patients
16%
Chemotherapy
16%
Medical Records
16%
Patient Characteristics
16%
Retrospective Review
16%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
16%
Prognostic Biomarker
16%
Lymph Node Metastasis
16%
Cox Regression
16%
Liver Metastasis
16%
Survival Prediction
16%
Standardized Uptake Value
16%
Target Lesion
16%
Medicine and Dentistry
Metastatic Breast Cancer
100%
Hazard Ratio
100%
Overall Survival
100%
Fluorodeoxyglucose
100%
Glycolysis
83%
Lung
66%
Lymph Node
66%
Neoplasm
50%
Biological Marker
33%
Metastatic Carcinoma
33%
Bone Metastasis
33%
Breast Cancer
16%
Lymph Node Metastasis
16%
Medical Record
16%
Patient Characteristics
16%
Proportional Hazards Model
16%
Liver Metastasis
16%
Positron Emission Tomography-Computed Tomography
16%
Target Lesion
16%
Standardized Uptake Value
16%
Diseases
16%
Chemotherapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Breast Cancer
100%
Overall Survival
100%
Fluorodeoxyglucose
100%
Neoplasm
50%
Biological Marker
33%
Bone Metastasis
33%
Chemotherapy Regimens
16%
Breast Cancer
16%
Lymph Node Metastasis
16%
Liver Metastasis
16%
Diseases
16%
Immunology and Microbiology
Overall Survival
100%
Lymph Node
83%
Glycolysis
83%
Lung
66%
Metabolic Tumor Volume
50%
Medical Record
16%
Positron Emission Tomography-Computed Tomography
16%
Prognostic Biomarker
16%
Biochemistry, Genetics and Molecular Biology
Metabolic Tumor Volume
50%